# A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines

> **NCT01004653** · PHASE4 · COMPLETED · sponsor: **Sinovac Biotech Co., Ltd** · enrollment: 100 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** H1N1 influenza A Vaccine (Split virion), Inactivated

## Key facts

- **NCT ID:** NCT01004653
- **Lead sponsor:** Sinovac Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2009-10
- **Final completion:** 2009-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004653, "A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01004653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*